Feifei Zhang

CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade.

Ryan D. Chow, Y. Errami, Paul A. Renauer, 2020, Cancer discovery.

Rational design of immune gene therapy combinations via in vivo CRISPR activation screen of tumor microenvironment modulators

Ryan D. Chow, Guangchuan Wang, Sidi Chen, 2023, bioRxiv.

Multiplexed inhibition of immunosuppressive genes with Cas13d for on-demand combinatorial cancer immunotherapy

Ryan D. Chow, Guangchuan Wang, Sidi Chen, 2023, bioRxiv.

Multiplexed repression of immunosuppressive genes 2 as combinatorial cancer immunotherapy

Ryan D. Chow, Sidi Chen, Yueqi Zhang, 2023 .